Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: A 5-year cohort study of 15,622 Chinese subjects

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 703-709

  Tsoi, Kelvin K F ^a,b   Wong, Martin C S ^a   Tam, Wilson W S ^a   Hirai, Hoyee W ^b   Lao, X Q ^a   Wang, Harry H X ^a   Kwan, Mandy W M ^a   Cheung, Clement S K ^c   Tong, Ellen L H ^c   Cheung, N T ^c   Yan, Bryan P ^a   Meng, Helen M L ^b   Griffiths, Sian M ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

ACE inhibitor; All cause mortality; Cardiovascular related mortality; Lisinopril; Perindopril

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PERINDOPRIL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; PRESCRIPTION; TRENDS;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; COHORT STUDIES; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGED; MORTALITY; PERINDOPRIL;

EID: 84908253850     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.114     Document Type: Article

References (47)

1. J.A. Cutler, P.D. Sorlie, M. Wolz, T. Thom, L.E. Fields, and E.J. Roccella Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004 Hypertension 52 2008 818 827
2. D.M. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T.B. Ferguson, and K. Flegal Heart disease and stroke statistics - 2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee Circulation 119 2009 e21 e181
3. P.M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P.K. Whelton, and J. He Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223
4. B.M. Egan, Y. Zhao, and N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
5. Centre for Health Protection Non communicate diseases and risk factors - hypertension Available at http://www.chp.gov.hk/en/content/9/25/60.html [Accessed on 4 April, 2014]
6. C.M. Lawes, S.V. Hoorn, and A. Rodgers Global burden of blood-pressure-related disease, 2001 Lancet 371 2008 1513 1518
7. G.L. Bakris, M. Williams, and L. Dworkin Preserving renal function in adults with hypertension and diabetes: a consensus approach Am J Kidney Dis 36 2000 646 661
8. Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomize trials Br Med J 336 2008 1121 1123
9. Q. Gu, V.L. Burt, C.F. Dillon, and S. Yoon Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension Circulation 126 2012 2105 2114
10. P. Kearney, M. Whelton, K. Reynolds, P.K. Whelton, and J. He Worldwide prevalence of hypertension: a systematic review J Hypertens 22 2004 11 19
11. S. Panjabi, M. Lacey, T. Bancroft, and F. Cao Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients J Am Soc Hypertens 7 2013 46 60
12. K. Wolf-Maier, R.S. Cooper, and H. Kramer Hypertension treatment and control in five European countries, Canada, and the United States Hypertension 43 2004 10 17
13. N.M. Kaplan, and R.G. Victor Chapter 7. Treatment of hypertension: drug therapy 10th ed. Kaplan's Clinical Hypertension 2010 Lippincott Williams & Wilkins, a Wolters Kluwer business 192 273
14. G. Mancia, S. Laurent, and E. Agabiti-Rosei European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
15. P.A. James, S. Oparil, and B.L. Carter 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
16. National Collaborating Centre for Chronic Conditions Hypertension: clinical management of primary hypertension in adults NICE guideline draft February 2011 [Available at http://www.nice.org.uk/nicemedia/live/12167/53225/53225.pdf. Accessed on 4 April, 2014]
17. L.H. Lindholm, B. Carlberg, and O. Samuelsson Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 2005 1545 1553
18. R. Garg, S. Yusuf, and W.D. Bussmann Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials JAMA 273 1995 1450 1456
19. B. Neal, S. MacMahon, and N. Chapman Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration Lancet 356 2000 1955 1964
20. B.J. Epstein, and J.G. Gums Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations Ann Pharmacother 39 2005 470 480
21. C.M. White Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors Pharmacotherapy 18 1998 588 599
22. L. Pilote, M. Abrahamowicz, M. Eisenberg, K. Humphries, H. Behlouli, and J.V. Tu Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure CMAJ 178 2008 1303 1311
23. L. Pilote, M. Abrahamowicz, E. Rodrigues, M.J. Eisenberg, and E. Rahme Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med 141 2004 102 112
24. M.C. Wong, W.W. Tam, and C.S. Cheung Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study Int J Cardiol 168 2013 928 933
25. M.C. Wong, W.W. Tam, and H.H. Wang Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study Int J Cardiol 168 2013 4705 4710
26. M.C.S. Wong, W.W. Tam, and C.S. Cheung Antihypertensive prescriptions over a 10-year period in a large Chinese population Am J Hypertens 26 2013 931 938
27. M.C. Wong, W.W. Tam, and X.Q. Lao The effectiveness of metoprolol versus atenolol on prevention of all-cause and cardiovascular mortality in a large Chinese population: a cohort study Int J Cardiol 175 3 Aug 20 2014 425 432
28. M.C.S. Wong, Y. Jiang, J.L. Tang, A. Lam, H. Fung, and S.W. Mercer Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data BMC Health Serv Res 8 2008 138
29. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Adherence to combination therapy among ethnic Chinese patients: a cohort study Hypertens Res 33 2010 416 421
30. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study Clin Ther 31 2009 2170 2177
31. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study J Clin Pharmacol 50 2010 598 605
32. M.C.S. Wong, J.Y. Jiang, and S.M. Griffiths Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients Am J Hypertens 22 2009 904 910
33. M.C. Wong, W.W. Tam, and C.S. Cheung Initial antihypertensive prescription and switching: a 5 year cohort study from 250,851 patients PLoS One 8 1 2013 e53625
34. C.M. Schooling, T.H. Lam, and Z.B. Li Obesity, physical activity, and mortality in a prospective Chinese elderly cohort Arch Intern Med 166 2006 1498 1504
35. T.H. Lam, S.Y. Ho, A.J. Hedley, K.H. Mak, and R. Peto Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998 BMJ 2001 1998 323 361
36. M.C.S. Wong, W.W. Tam, and C.S. Cheung Medication adherence to first-line antihypertensive drug class in a large Chinese population Int J Cardiol 167 2013 1438 1442
37. N.K. Choudhry, W.H. Shrank, and R.L. Levin Measuring concurrent adherence to multiple related medications Am J Managed Care 15 2009 457 464
38. B.C. Martin, E.K. Wiley-Exley, S. Richards, M.E. Domino, T.S. Carey, and B.L. Sleath Contrasting measures of adherence with sampling drug use, medication switching and therapeutic duplication Ann Pharmacother 43 2009 36 44
39. L.M. Hess, M.A. Raebel, D.A. Conner, and D.C. Malone Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures Ann Pharmacother 40 2006 1280 1288
40. G. Mazzaglia, E. Ambrosioni, and M. Alacqua Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients Circulation 120 2009 1598 1605
41. J.N. Rasmussen, A. Chong, and D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2007 177 186
42. S.E. Andrade, K.H. Kahler, F. Frech, and K.A. Chan Methods for evaluation of medication adherence and persistence using automated databases Pharmacoepidemiol Drug Saf 15 2006 565 574
43. D.R. Cox Regression models and life-tables Journal of the Royal Statistical Society B 34 1972 187 220
44. I.A. Dhalla, T. Gomes, and Z. Yao Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults Ann Intern Med 158 2013 447 455
45. S. Schneeweiss, J.A. Rassen, R.J. Glynn, J. Avorn, H. Mogun, and M.A. Brookhart High-dimensional propensity score adjustment in studies of treatment effects using health care claims data Epidemiology 20 2009 512 522
46. T. Gomes, D.N. Juurlink, J.M. Ho, S. Schneeweiss, and M.M. Mamdani Risk of serious falls associated with oxybutynin and tolterodine: a population based study J Urol 186 2011 1340 1344
47. M.J. Brown Hypertension and ethnic group BMJ 332 2006 833 836